• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

hMLH1 基因中的一个多态性(-93G-->A)与肺癌易感性和预后相关。

A polymorphism in the hMLH1 gene (-93G-->A) associated with lung cancer susceptibility and prognosis.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C.

出版信息

Int J Mol Med. 2010 Jan;25(1):165-70.

PMID:19956916
Abstract

Polymorphisms in DNA repair genes may be associated with differences in repair capacity of DNA damage and may thereby influence an individual's susceptibility to lung cancer. We investigated the association between the -93G-->A polymorphism in the mismatch repair hMLH1 gene for its role in the susceptibility and survival of non-small cell lung cancer (NSCLC) patients. Using a case-control study design, 165 NSCLC patients and 193 controls with similar range for age, gender and smoking habit distributions were subjected to genotype analysis. The risk of lung cancer was estimated by logistic regression analysis. The Kaplan-Meier method was used to estimate the probability of survival and the log-rank test was used to assess the significance of the difference between survival probabilities. The homozygous variant A/A genotype was associated with a significantly increased risk for lung cancer compared with the other genotypes (Crude analysis P=0.003, Adjusted analysis P=0.011, using the logistic regression model). The patients with a homozygous variant A/A genotype had a trend toward poorer prognoses compared with other patients, especially smoking (P=0.05, by log-rank test), male (P=0.06), or squamous carcinoma (P=0.08) patients. This is the first case-control study to show a significant association between the hMLH1-93G-->A polymorphism and the susceptibility to and prognosis of lung cancer. The results herein may be useful for risk assessment and disease monitoring of NSCLC.

摘要

DNA 修复基因的多态性可能与 DNA 损伤修复能力的差异有关,并可能影响个体对肺癌的易感性。我们研究了错配修复 hMLH1 基因中的-93G-->A 多态性与非小细胞肺癌(NSCLC)患者易感性和生存的关系。采用病例对照研究设计,对 165 例 NSCLC 患者和 193 例年龄、性别和吸烟习惯分布相似的对照进行基因型分析。使用逻辑回归分析估计肺癌的风险。Kaplan-Meier 法估计生存概率,对数秩检验评估生存概率差异的显著性。与其他基因型相比,杂合子变异 A/A 基因型与肺癌的风险显著增加(粗分析 P=0.003,调整分析 P=0.011,使用逻辑回归模型)。与其他患者相比,具有纯合子变异 A/A 基因型的患者预后较差,尤其是吸烟(P=0.05,对数秩检验)、男性(P=0.06)或鳞状细胞癌(P=0.08)患者。这是第一项表明 hMLH1-93G-->A 多态性与肺癌易感性和预后之间存在显著关联的病例对照研究。本研究结果可能有助于 NSCLC 的风险评估和疾病监测。

相似文献

1
A polymorphism in the hMLH1 gene (-93G-->A) associated with lung cancer susceptibility and prognosis.hMLH1 基因中的一个多态性(-93G-->A)与肺癌易感性和预后相关。
Int J Mol Med. 2010 Jan;25(1):165-70.
2
-93G-->A polymorphism of hMLH1 and risk of primary lung cancer.人错配修复基因1(hMLH1)的-93G→A多态性与原发性肺癌风险
Int J Cancer. 2004 Nov 20;112(4):678-82. doi: 10.1002/ijc.20359.
3
Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.非同源末端连接途径基因多态性与肺癌易感性及预后的关系:一项多基因型-表型研究。
Cancer. 2009 Jul 1;115(13):2939-48. doi: 10.1002/cncr.24327.
4
Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking.错配修复基因多态性与结肠直肠息肉:hMLH1-93G>A变异体改变吸烟相关风险。
Am J Gastroenterol. 2006 Jun;101(6):1313-9. doi: 10.1111/j.1572-0241.2006.00551.x.
5
DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer.在非小细胞肺癌手术切除后,hMLH1的DNA甲基化与对顺铂的临床反应相关。
Int J Clin Exp Pathol. 2015 May 1;8(5):5457-63. eCollection 2015.
6
Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer.CXCL12/SDF1 基因及其受体 CXCR4 的遗传多态性与非小细胞肺癌易感性和预后的关系。
Lung Cancer. 2011 Aug;73(2):147-52. doi: 10.1016/j.lungcan.2010.12.011. Epub 2011 Feb 2.
7
Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas.原发性非小细胞肺癌中错配修复蛋白hMSH2和hMLH1的表型基因表达谱
Lung Cancer. 2009 Jun;64(3):282-8. doi: 10.1016/j.lungcan.2008.09.018. Epub 2008 Dec 3.
8
Mismatch repair gene polymorphisms and association with lung cancer development.错配修复基因多态性及其与肺癌发生的关联。
Adv Exp Med Biol. 2015;833:15-22. doi: 10.1007/5584_2014_83.
9
Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance.错配修复蛋白hMLH1/hMSH2在非小细胞肺癌组织中的表达及其临床意义。
J Surg Oncol. 2008 Oct 1;98(5):377-83. doi: 10.1002/jso.21108.
10
Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians.hMLH1 启动子中单核苷酸多态性与高危亚洲人群中烟草相关口腔癌的风险。
Gene. 2013 Sep 10;526(2):223-7. doi: 10.1016/j.gene.2013.05.014. Epub 2013 May 31.

引用本文的文献

1
The role of DNA mismatch repair in immunotherapy of human cancer.DNA 错配修复在人类癌症免疫治疗中的作用。
Int J Biol Sci. 2022 Apr 4;18(7):2821-2832. doi: 10.7150/ijbs.71714. eCollection 2022.
2
DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers.散发性实体瘤中的 DNA 错配修复基因变异。
Int J Mol Sci. 2020 Aug 3;21(15):5561. doi: 10.3390/ijms21155561.
3
Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy.
错配修复通路基因多态性可预测接受辅助同步放化疗的口腔鳞状细胞癌患者的临床结局。
Cancers (Basel). 2019 Apr 29;11(5):598. doi: 10.3390/cancers11050598.
4
Pooling-analysis on hMLH1 polymorphisms and cancer risk: evidence based on 31,484 cancer cases and 45,494 cancer-free controls.hMLH1基因多态性与癌症风险的汇总分析:基于31484例癌症病例和45494例无癌对照的证据
Oncotarget. 2017 Oct 10;8(54):93063-93078. doi: 10.18632/oncotarget.21810. eCollection 2017 Nov 3.
5
The dynamic DNA methylation landscape of the shore is altered by -93G>A polymorphism in normal tissues and colorectal cancer.正常组织和结直肠癌中-93G>A多态性改变了岸区的动态DNA甲基化格局。
Clin Epigenetics. 2017 Mar 9;9:26. doi: 10.1186/s13148-017-0326-6. eCollection 2017.
6
The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population.中国人中hMLH1基因-93G>A多态性与卵巢癌风险
PLoS One. 2015 Aug 14;10(8):e0135822. doi: 10.1371/journal.pone.0135822. eCollection 2015.
7
The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer.hMLH1/hMSH2基因多态性对结直肠癌的预后意义。
Med Oncol. 2014 Jun;31(6):975. doi: 10.1007/s12032-014-0975-7. Epub 2014 May 4.
8
Expression of the mismatch repair gene hMLH1 is enhanced in non-small cell lung cancer with EGFR mutations.错配修复基因hMLH1在伴有表皮生长因子受体(EGFR)突变的非小细胞肺癌中表达增强。
PLoS One. 2013 Oct 24;8(10):e78500. doi: 10.1371/journal.pone.0078500. eCollection 2013.
9
DNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial.β-胡萝卜素与视黄醇功效试验中的DNA修复基因型与肺癌风险
Int J Mol Epidemiol Genet. 2013;4(1):11-34. Epub 2013 Mar 18.
10
Association between p53 codon 72 genetic polymorphisms and tobacco use and lung cancer risk in a Chinese population.p53 密码子 72 遗传多态性与中国人群中吸烟和肺癌风险的关系。
Mol Biol Rep. 2013 Jan;40(1):645-9. doi: 10.1007/s11033-012-2103-0. Epub 2012 Oct 11.